Rapamycin reduces seizure frequency in tuberous sclerosis complex
- PMID: 19151365
- PMCID: PMC3072696
- DOI: 10.1177/0883073808324535
Rapamycin reduces seizure frequency in tuberous sclerosis complex
Abstract
The authors present a 10-year-old girl with tuberous sclerosis complex who has been receiving rapamycin for 10 months for seizure control. She was started at 0.05 mg/kg/d and titrated to an effective dose of 0.15 mg/kg/d. There was a dramatic reduction in seizure frequency with rapamycin therapy. Further studies are needed to objectively investigate the benefits of rapamycin in tuberous sclerosis complex and to clarify its mechanism of seizure control.
Conflict of interest statement
The authors have no conflicts of interest to disclose with regard to this article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical